In: Antimicrobial Agents and Chemotherapy, 2019, vol. 63, no. 1, p. e01809-18
A clinical Pseudomonas aeruginosa isolate resistant to all β-lactams, including ceftolozane-tazobactam and carbapenems, was recovered. It belonged to sequence type 235 and produced the extended-spectrum β-lactamase (ESBL) GES-6 differing from GES-1 by two amino acid substitutions (E104K and G170S). GES-6 possessed an increased hydrolytic activity toward carbapenems and to ceftolozane and a ...
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2017, p. 1–9
The novel siderophore cephalosporin cefiderocol (S-649266) with potent activity against Gram-negative pathogens was recently developed (Shionogi & Co., Ltd.). Here, we evaluated the activity of this new molecule and comparators against a collection of previously characterized Gram-negative isolates using broth microdilution panels. A total of 753 clinical multidrug-resistant Gram-negative...
|
In: Clinical Infectious Diseases, 2008, vol. 46, no. 4, p. e38-e40
|
In: Clinical Infectious Diseases, 2003, vol. 37, no. 5, p. 726-727
|
In: Journal of the Pediatric Infectious Diseases Society, 2015, vol. 4, no. 3, p. e32-e37
|
In: Journal of Antimicrobial Chemotherapy, 2011, vol. 66, no. 5, p. 1168-1173
|
In: Clinical Infectious Diseases, 2015, vol. 61, no. 6, p. e26-e46
|
In: Infection Control & Hospital Epidemiology, 2013, vol. 34, no. 10, p. 1109-1112
|
In: Antimicrobial Agents and Chemotherapy, 2016, vol. 60, no. 5, p. 3199–3201
An extended-spectrum β-lactamase (ESBL)-producing and colistin-resistant Klebsiella pneumoniae clinical isolate was recovered from a patient who was treated with cefotaxime. This isolate harbored a blaCTX-M-15 ESBL gene that was associated with an ISEcp1 insertion sequence. Transposition of that tandem occurred within the chromosomal mgrB gene, leading...
|
In: BMC Infectious Diseases, 2015, vol. 15, p. 512
Extended-spectrum β-lactamases producing Escherichia coli (ESBL-E) are increasingly identified in health care facilities. As previously done for the control of methicillin-resistant Staphylococcus aureus, many hospitals have established screening strategies for early identification of patients being carriers of ESBL producers in general and ESBL-E in particular, and have implemented contact...
|